The global neuroendocrine carcinoma treatment market is projected to grow significantly, with an estimated value of USD 1,976 million in 2024 and a compound annual growth rate (CAGR) of 8.1% from 2024 to 2034. This growth trajectory is expected to propel the market size to approximately USD 4,305.7 million by 2034, reflecting the increasing incidence …
Tag Archives: Neuroendocrine Carcinoma Treatment Market
Neuroendocrine Carcinoma Treatment Market to Reach US$ 2.9 Billion by 2029, Driven By Growth of Peptide Receptor Radionuclide Therapy and Immunotherapy | FMI
The global Neuroendocrine Carcinoma Treatment Market is anticipated to reach US$ 1.7 billion in 2022. By the end of 2029, it is anticipated that this market will have grown to US$ 2.9 billion, with sales revenue expected to experience a CAGR of 8.0%. The Neuroendocrine Carcinoma Treatment Market is witnessing significant growth and innovation in …
Neuroendocrine Carcinoma Treatment Market is likely to register CAGR of 8% through 2029
The Global Neuroendocrine Carcinoma Treatment Market size is expected to reach US$ 1.7 Billion in 2022 with a CAGR of 8.0%, indicating favourable market growth during the projected period. Neuroendocrine Carcinoma Treatment Market is expected to reach US$ 2.9 billion by 2029. According to Future Market Insights, the market for somatostatin analogs as a therapy type is …